Samuel S Engel

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 13

Top Topics

Glycemic Control

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Diabetes therapy : research, treatment and education of diabetes and related disorders

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Kohei Kaku, Takashi Kadowaki, Yutaka Seino, Taro Okamoto, Masayoshi Shirakawa, Asako Sato, Edward A O'Neill, Samuel S Engel, Keith D Kaufman
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin. Diabetes, obesity & metabolism 23 (9) (2021)
Takashi Kadowaki, Yutaka Seino, Kohei Kaku, Taro Okamoto, Miho Kameya, Asako Sato, Tomona Hirano, Nobuyuki Oshima, Ira Gantz, Edward A O'Neill, Samuel S Engel, null null
A randomized, placebo-controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control. Diabetes, obesity & metabolism 23 (6) (2021)
Yutaka Seino, Kohei Kaku, Takashi Kadowaki, Taro Okamoto, Asako Sato, Masayoshi Shirakawa, Edward A O'Neill, Samuel S Engel, Keith D Kaufman
A randomized, placebo-controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin. Diabetes, obesity & metabolism 23 (6) (2021)
Annaswamy Raji, Zhi Jin Xu, Raymond L H Lam, Edward A O'Neill, Keith D Kaufman, Samuel S Engel
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (10) (2020)
Juan Pablo Frias, Zachary Zimmer, Raymond L H Lam, Guillermo Amorin, Catherine Ntabadde, Carol Iredale, Edward A O'Neill, Samuel S Engel, Keith D Kaufman, Hideo Makimura, Michael F Crutchlow
Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT-M study. Diabetes, obesity & metabolism 21 (5) (2019)
Miao Yu, R Ravi Shankar, Ruya Zhang, Ye Zhang, Jianxin Lin, Edward A O'Neill, Guojuan Chen, Shu Liu, Yingmei Tu, Samuel S Engel
Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin. Diabetes, obesity & metabolism 21 (2) (2018)
M Angelyn Bethel, Samuel S Engel, Susanna R Stevens, Yuliya Lokhnygina, Jie Ding, Robert G Josse, Michael Alvarsson, Irene Hramiak, Jennifer B Green, Eric D Peterson, Rury R Holman, null null
Progression of glucose-lowering diabetes therapy in TECOS. Endocrinology, diabetes & metabolism 2 (1) (2018)
Joakim Alfredsson, Jennifer B Green, Susanna R Stevens, Shelby D Reed, Paul W Armstrong, M Angelyn Bethel, Samuel S Engel, Darren K McGuire, Frans Van de Werf, Irene Hramiak, Harvey D White, Eric D Peterson, Rury R Holman, null null
Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS. Diabetes, obesity & metabolism 20 (10) (2018)
Russell Scott, Jerry Morgan, Zachary Zimmer, Raymond L H Lam, Edward A O'Neill, Keith D Kaufman, Samuel S Engel, Annaswamy Raji
A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R study. Diabetes, obesity & metabolism 20 (12) (2018)
Ira Gantz, Taro Okamoto, Yuka Ito, Kotoba Okuyama, Edward A O'Neill, Keith D Kaufman, Samuel S Engel, Eseng Lai, null null
A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes. Diabetes, obesity & metabolism 19 (11) (2017)
Samuel S Engel, Shailaja Suryawanshi, Susanna R Stevens, Robert G Josse, Jan H Cornel, Neli Jakuboniene, Axel Riefflin, Tsvetalina Tankova, Julio Wainstein, Eric D Peterson, Rury R Holman, null null
Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS. Diabetes, obesity & metabolism 19 (11) (2017)
Anthony P Nunes, Kristy Iglay, Larry Radican, Samuel S Engel, Jing Yang, Michael C Doherty, David D Dore
Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users. Diabetes, obesity & metabolism 19 (10) (2017)
Craig J Currie, Sarah E Holden, Sara Jenkins-Jones, Christopher Ll Morgan, Bernd Voss, Swapnil N Rajpathak, Berhanu Alemayehu, John R Peters, Samuel S Engel
Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival. Diabetes, obesity & metabolism 20 (4) (2017)